SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 179 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,133,000 | -85.0% | 311,400 | -65.8% | 0.27% | -88.9% |
| Q3 2019 | $7,563,000 | +45.4% | 911,719 | +50.9% | 2.44% | +94.3% |
| Q2 2019 | $5,201,000 | -12.2% | 604,019 | +9.0% | 1.25% | -21.6% |
| Q1 2019 | $5,922,000 | +398.5% | 554,019 | +683.5% | 1.60% | +291.9% |
| Q3 2018 | $1,188,000 | -60.5% | 70,712 | -50.7% | 0.41% | -75.5% |
| Q2 2018 | $3,009,000 | – | 143,550 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
| ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
| NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
| Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
| Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
| Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
| J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
| J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
| Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |